“Bridging Immunology and Therapy: New Perspectives on MIMID” is a high-level,  multi-specialty scientific congress dedicated to exploring the evolving landscape of  immune-mediated diseases. While rheumatology anchors the program, the congress  goes further—integrating insights from multiple disciplines affected by immune  dysregulation. With an evidence-based, future-focused agenda, the congress is designed to connect  specialists, clinical researchers, and pharmaceutical leaders, offering a strategic look at  how immune-driven therapies are being applied—and expanded—across specialties.